Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
about
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@en
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@nl
type
label
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@en
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@nl
prefLabel
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@en
Dual Antiplatelet Therapy and ...... ts From the TRILOGY ACS Trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dual Antiplatelet Therapy and ...... hts From the TRILOGY ACS Trial
@en
P2093
Derek D Cyr
E Magnus Ohman
Felipe Martinez
Harvey D White
Jonathan P Piccini
Kenneth J Winters
Larry R Jackson
Matthew T Roe
Megan L Neely
Ramón Corbalán
P2860
P304
P356
10.1002/CLC.22562
P577
2016-07-28T00:00:00Z